/
NUS
$5.27-$0.01 (-0.19%)prev close
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$256.3M
49M shares
52-week range
$4.89 – $14.62
4% from low
Sector
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-51.39
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.68B | $2.42B | $2.58B | $2.70B | $2.23B | $1.97B | $1.73B | $1.49B |
| Cost of revenue | $634.1M | $581.4M | $658.0M | $675.2M | $630.9M | $611.9M | $550.2M | $453.8M |
| Gross profit | $2.04B | $1.84B | $1.92B | $2.02B | $1.59B | $1.36B | $1.18B | $1.03B |
| Gross margin | 76.3% | 76.0% | 74.5% | 75.0% | 71.7% | 68.9% | 68.2% | 69.4% |
| R&D | $23.0M | $0 | $23.3M | $27.2M | $0 | $22.6M | $13.0M | $0 |
| Operating income | $240.9M | $267.4M | $257.6M | $234.0M | $110.8M | $48.3M | −$151.6M | $90.9M |
| EBITDA | $394.5M | $344.1M | $331.6M | $368.5M | $175.0M | $203.0M | −$78.8M | $262.4M |
| Net income | $121.9M | $173.6M | $191.4M | $147.3M | $104.8M | $8.6M | −$146.6M | $160.2M |
| Net margin | 4.5% | 7.2% | 7.4% | 5.5% | 4.7% | 0.4% | -8.5% | 10.8% |
| EPS (diluted) | 2.16 | 3.10 | 3.63 | 2.86 | 2.07 | 0.17 | -2.95 | 3.18 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.4B | $1.00 | $1.00–$1.00 | 1 |
| 2027 | $1.5B | $1.32 | $1.32–$1.32 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$26.77
Price
$5.27
Implied upside
+408%
Peer comparison
NuSkin Enterprises, Inc.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
www.nuskin.com- Employees
- 8,600
- IPO / List date
- Nov 22, 1996
- HQ
- PROVO, UT
Held by traders on TradeandTell
No one on the platform currently holds NUS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,700,496 | $12.4M |
| Bridgewater Associatesas of 2024-09-30 | 32,402 | $238.8K |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 4.55% ($0.24/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-29 | $0.0600 | 2026-06-10 |
| 2026-02-27 | $0.0600 | 2026-03-11 |
| 2025-11-28 | $0.0600 | 2025-12-10 |
| 2025-08-29 | $0.0600 | 2025-09-10 |
| 2025-05-30 | $0.0600 | 2025-06-11 |
| 2025-02-24 | $0.0600 | 2025-03-05 |
| 2024-11-29 | $0.0600 | 2024-12-11 |
| 2024-08-30 | $0.0600 | 2024-09-11 |
| 2024-05-31 | $0.0600 | 2024-06-12 |
| 2024-02-23 | $0.0600 | 2024-03-06 |
Recent trades on TradeandTell
No one on the platform has traded NUS yet.
